SmithKline Beecham SWG Limited

SmithKline Beecham SWG Limited, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of GSK plc, and as such, it inherits emissions data and climate commitments from its parent organization.

GSK plc has set ambitious climate targets, which are cascaded down to SmithKline Beecham SWG Limited. These initiatives include commitments to reduce carbon emissions across all scopes, with a focus on achieving net-zero emissions by 2030 for its own operations (Scope 1 and 2) and by 2045 for its value chain (Scope 3). The company is actively participating in the Science Based Targets initiative (SBTi) and has aligned its climate strategies with industry standards.

While specific reduction targets for SmithKline Beecham SWG Limited are not detailed, the overarching goals from GSK plc reflect a strong commitment to sustainability and climate action. The company is also involved in various initiatives such as the Carbon Disclosure Project (CDP) and RE100, which further demonstrate its dedication to reducing its carbon footprint and promoting renewable energy usage.

In summary, while specific emissions data for SmithKline Beecham SWG Limited is not available, the company's climate commitments are robust and aligned with its parent company's strategic goals for sustainability and emissions reduction.